Log In
BCIQ
Print this Print this
 

CRV431

  Manage Alerts
Collapse Summary General Information
Company ContraVir Pharmaceuticals Inc.
DescriptionCyclophilin inhibitor
Molecular Target Cyclophilin
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationHepatitis B virus (HBV)
Indication DetailsTreat HBV infection
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today